ERBB2 and breast cancer: Luminal B tumors, which account for approximately 20% of all BC, show a lower expression of estrogen receptor (ER), lower or no expression of progesterone receptor (PgR), and higher proliferation compared to luminal A cancers and can be HER2 positive [4, 5].